Compass Competitors

Delisted . USA . 
Stock . Compass Biotechnologies
Analyzing Compass Biotechnologies competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Compass Biotechnologies to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Compass Biotechnologies vs Imaging Dynamics Correlation

Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.000.000.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.000.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Compass Biotechnologies. Your research has to be compared to or analyzed against Compass Biotechnologies' peers to derive any actionable benefits. When done correctly, Compass Biotechnologies' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Compass Biotechnologies.

Compass Biotechnologies Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Compass Biotechnologies and its competitors represents the degree of relationship between the price movements of corresponding delisted stocks. A correlation of about +1.0 implies that the price of Compass and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Compass Biotechnologies does not affect the price movement of the other competitor.

High positive correlations

IDYLF
+ 1.0
PFND
MCET
+ 0.32
BITRF
ERBB
+ 0.27
BITRF
ERBB
+ 0.21
IPIX
TSOI
+ 0.14
IPIX
ERBB
+ 0.11
TSOI
  

High negative correlations

ERBB
- 0.5
BPTSY
TSOI
- 0.4
BPTSY
RSPI
- 0.37
BITRF
IPIX
- 0.31
BPTSY
BITRF
- 0.2
BPTSY
MCET
- 0.11
BPTSY

Risk-Adjusted Indicators

There is a big difference between Compass Stock performing well and Compass Biotechnologies Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Compass Biotechnologies' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
BPTSY  63.68  28.73  0.00  8.61  0.00 
 0.00 
 0.00 
 0.00 
 1,000.00 
BITRF  50.59  22.16  0.00 (42.48) 0.00 
 0.00 
 0.00 
(18.75)
 1,765 
RSPI  1.83  0.82  0.00  2.36  0.00 
 0.00 
 0.00 
 0.00 
 33.94 
PFND  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
MCET  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
IPIX  32.13  10.93  0.31  2.43  20.11 
(86.94)
 110.00 
(50.00)
 372.22 
TSOI  64.67  34.78  0.00 (0.34) 0.00 
 0.00 
 0.00 
 0.00 
 1,100 
ERBB  14.35  2.48  0.07 (1.43) 14.03 
(45.45)
 50.00 
(33.33)
 83.33 
IDYLF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 

Compass Biotechnologies Competitive Analysis

The better you understand Compass Biotechnologies competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Compass Biotechnologies' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Compass Biotechnologies' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
BPTSY BITRF RSPI PFND IPIX TSOI ERBB IDYLF
 0.00 
 0.50 
Biophytis
 0.00 
 0 
Biotron
 0.00 
 0 
RespireRx
 0.00 
 0.0001 
Pathfinder
 142.86 
 0 
Innovation
 0.00 
 0.0001 
Therapeutic
 33.33 
 0.0002 
American
 0.00 
 0.02 
Imaging
Market Volatility
(90 Days Market Risk)
Out of control
Out of control
Out of control
Very steady
Out of control
Out of control
Out of control
Very steady
Market Performance
(90 Days Performance)
Good
Fair
Fair
Weakest
Good
Good
Fair
Weakest
Odds of Financial Distress
(Probability Of Bankruptcy)
Unknown
Small
Small
Small
High
Small
Low
High
Current Valuation
(Equity Enterprise Value)
Under Valued
Under Valued
Over Valued
Over Valued
Over Valued
Over Valued
Fairly Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Cautious Hold
Strong Sell
Strong Sell
Strong Sell
Sell
Strong Sell
Strong Sell
Strong Sell
Current Ratio
N/A
2.35 X
0.01 X
N/A
0.60 X
0.36 X
0.01 X
0.10 X
Net Asset
N/A
1.91 M
208.74 K
106 K
10.38 M
1.72 M
2.49 M
412.46 K
Profit Margin
N/A
(1.78) %
N/A
N/A
N/A
N/A
N/A
N/A
EBITDA
N/A
(2.73 M)
(2.42 M)
(1.67 M)
(6.54 M)
(2.33 M)
(639.96 K)
(533.58 K)
Current Valuation
N/A
15.31 M
3.18 M
7.41 M
7.56 M
21.6 M
2.83 M
3.6 M
Price To Book
N/A
23.61 X
N/A
N/A
2.95 X
11.55 X
N/A
N/A
Operating Margin
N/A
(1.78) %
N/A
N/A
(339.83) %
(13.37) %
(13.84) %
(5.65) %
Retained Earnings
N/A
(37 M)
(156.09 M)
(19.23 M)
(87.38 M)
(3.21 M)
(31.05 M)
N/A
Current Asset
N/A
3 M
157 K
9 K
529.15 K
247 K
159 K
N/A
Beta
N/A
-1.2
0.24
0.14
0.18
1.49
1.39
-1.77
Number Of Employees
N/A
10
2
1
4
3
9
15
Shares Outstanding
N/A
901.94 M
119.59 M
667.16 M
488.32 M
2.61 B
29.74 B
10.33 M
Cash Flow From Operations
N/A
(2.44 M)
(956.17 K)
(963 K)
(6.28 M)
(718.92 K)
(1.42 M)
(496.75 K)
Total Debt
N/A
77.24 K
2.42 M
5.41 M
1.24 M
15.53 K
686.28 K
25.73 K
Return On Equity
N/A
-1.12
N/A
N/A
-1.09
-12.27
N/A
N/A
Z Score
N/A
N/A
N/A
N/A
-7.0
N/A
13.2
N/A
Return On Asset
N/A
-0.56
-8.34
-8.89
-0.32
-0.76
N/A
-1.45
Book Value Per Share
N/A
0 X
(0.1) X
(0.01) X
0.01 X
0 X
(0.46) X
(0.28) X
Number Of Shares Shorted
N/A
N/A
126
N/A
N/A
N/A
N/A
N/A
Current Liabilities
N/A
N/A
5.05 M
6.77 M
484.43 K
489 K
8.3 M
N/A
Total Asset
N/A
1.91 M
208.74 K
106 K
10.38 M
1.72 M
2.49 M
412.46 K
Debt To Equity
N/A
0.07 %
N/A
N/A
0.36 %
0.50 %
N/A
8.44 %
Short Ratio
N/A
N/A
1.47 X
N/A
N/A
N/A
N/A
N/A
Target Price
N/A
N/A
0.3
N/A
N/A
N/A
N/A
N/A
Market Capitalization
N/A
18.67 M
837.16 K
2 M
9.52 M
7.82 M
38.66 M
9.05 M
Price To Earning
N/A
(3.04) X
(0.25) X
N/A
(7.57) X
(8.00) X
N/A
N/A
Price To Sales
N/A
11.17 X
1,051 X
N/A
557.16 X
81.80 X
736.84 X
53.43 X
Net Income
N/A
(2.78 M)
(3.14 M)
(1.39 M)
(7.04 M)
(2.96 M)
(1.87 M)
(693.74 K)
Earnings Per Share
N/A
(0) X
(0.04) X
N/A
(0.02) X
(0) X
(0.15) X
(0.06) X
Shares Owned By Insiders
N/A
14.13 %
20.63 %
N/A
10.10 %
27.98 %
N/A
52.30 %
Revenue
N/A
1.56 M
N/A
N/A
18 K
145.96 K
39.34 K
253.32 K
Working Capital
N/A
3 M
(4.89 M)
(6.76 M)
44.72 K
(242 K)
(8.14 M)
N/A
Cash And Equivalents
N/A
1.74 M
21
4 K
2.97 M
197.29 K
1.76 K
56.68 K
Cash Per Share
N/A
N/A
N/A
N/A
0.01 X
N/A
N/A
N/A
Gross Profit
N/A
1.56 M
N/A
N/A
18 K
103.41 K
48.63 K
230.59 K
Day Typical Price
0.5
0.003
0.0018
1.0E-4
0.0017
1.0E-4
2.0E-4
0.0235
Accumulation Distribution
N/A
N/A
N/A
N/A
N/A
N/A
0.33
N/A
Market Facilitation Index
N/A
N/A
N/A
N/A
N/A
N/A
1.0E-4
N/A
Daily Balance Of Power
0.0
0.0
0.0
0.0
9.2 T
0.0
(1.00)
0.0
Period Momentum Indicator
N/A
N/A
N/A
N/A
0.001
N/A
(0.0001)
N/A
Rate Of Daily Change
1.0
1.0
1.0
1.0
2.43
1.0
0.67
1.0
Day Median Price
0.5
0.003
0.0018
1.0E-4
0.0017
1.0E-4
3.0E-4
0.0235
Price Action Indicator
N/A
N/A
N/A
N/A
5.0E-4
N/A
(0.0001)
N/A
Relative Strength Index
43.17
37.34
N/A
N/A
57.08
50.0
46.44
N/A
Coefficient Of Variation
626.71
945.04
582.78
N/A
554.3
608.48
949.38
N/A
Mean Deviation
63.68
50.59
1.83
N/A
32.13
64.67
14.35
N/A
Jensen Alpha
28.73
22.16
0.8239
N/A
10.93
34.78
2.48
N/A
Total Risk Alpha
15.48
6.62
0.4748
N/A
6.59
16.46
0.7012
N/A
Sortino Ratio
N/A
N/A
N/A
N/A
0.3057
N/A
0.0712
N/A
Downside Variance
N/A
N/A
N/A
N/A
1325.34
N/A
1076.39
N/A
Standard Deviation
181.24
209.23
4.97
N/A
62.04
182.54
22.78
N/A
Kurtosis
27.22
65.25
26.71
N/A
16.27
26.77
0.528
N/A
Potential Upside
N/A
N/A
N/A
N/A
110.0
N/A
50.0
N/A
Treynor Ratio
8.61
(42.48)
2.36
N/A
2.43
(0.34)
(1.43)
N/A
Maximum Drawdown
1000.0
1765.12
33.94
N/A
372.22
1100.0
83.33
N/A
Variance
32846.65
43778.77
24.73
N/A
3849.25
33322.03
518.73
N/A
Market Risk Adjusted Performance
8.62
(42.47)
2.37
N/A
2.44
(0.33)
(1.42)
N/A
Risk Adjusted Performance
0.1273
0.0878
0.1347
N/A
0.1426
0.1308
0.0872
N/A
Skewness
5.28
8.05
5.1
N/A
3.62
5.24
0.7042
N/A
Semi Deviation
N/A
N/A
N/A
N/A
20.11
N/A
14.03
N/A
Information Ratio
0.1592
0.1055
0.1586
N/A
0.1794
0.164
0.1025
N/A
Value At Risk
N/A
(18.75)
N/A
N/A
(50.00)
N/A
(33.33)
N/A
Expected Short fall
N/A
N/A
N/A
N/A
(86.94)
N/A
(45.45)
N/A
Downside Deviation
N/A
N/A
N/A
N/A
36.41
N/A
32.81
N/A
Semi Variance
N/A
N/A
N/A
N/A
404.38
N/A
196.89
N/A

Compass Biotechnologies Competition Performance Charts

Five steps to successful analysis of Compass Biotechnologies Competition

Compass Biotechnologies' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Compass Biotechnologies in relation to its competition. Compass Biotechnologies' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Compass Biotechnologies in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Compass Biotechnologies' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Compass Biotechnologies, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Compass Biotechnologies position

In addition to having Compass Biotechnologies in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Target Risk ETFs Thematic Idea Now

Target Risk ETFs
Target Risk ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Target Risk ETFs theme has 32 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Target Risk ETFs Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Consideration for investing in Compass Stock

If you are still planning to invest in Compass Biotechnologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Compass Biotechnologies' history and understand the potential risks before investing.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
AI Portfolio Prophet
Use AI to generate optimal portfolios and find profitable investment opportunities
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY